Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D?
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: exercise and vitamin D intake, vitamin D intake.
- Who it may be relevant to
- Registry conditions: Diabetes Mellitus, Erectile Dysfunction, Vitamin D Deficiency. Basic parameters: 35 years — 45 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
males with diabetes complain impotence in the presence of low vitamin D deficiency. pharacmological treatment of low vitamin D levels is necessary but changing lifestyle by performing exercise is also important
Detailed description
forty diabetic men (type 2) who complain presence of low vitamin D and impotence will be divided to group number I and group number II. Both groups will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.
Interventions
- Behavioral exercise and vitamin D intake
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks. - Other vitamin D intake
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks.
Primary outcome measures
- international index of erectile function [Time frame: it will be measured after 12 weeks]
Secondary outcome measures (9)
- glycated hemoglubin [Time frame: It will be measured after 12 weeks]
- fasting blood glcuose [Time frame: It will be measured after 12 weeks]
- body mass index [Time frame: It will be measured after 12 weeks]
- wasit circumference [Time frame: it will be measured after 12 weeks]
- high density lipoprotein [Time frame: It will be measured after 12 weeks]
- low density lipoprotein [Time frame: It will be measured after 12 weeks]
- triglycerides [Time frame: It will be measured after 12 weeks]
- cholesterol [Time frame: It will be measured after 12 weeks]
- 25-hydroxyvitamin D [Time frame: It will be measured after 12 weeks]
Eligibility criteria
Inclusion criteria
- diabetic men (forty)
- type 2 diabetes
- complaint of erectile dysfucntion (chronic complaint more than 24 months)
- men with low vitamin D (deiciency in vitamin D)
Exclusion criteria
- cardiac patients
- respiratory disease patients
- renal disease
- liver disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Cairo University — Dokki
Identifiers
NCT: NCT07366970 · IRB000-14233-64